<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Beginning April 25, Walgreens Healthcare Clinic locations in select 
 markets will offer testing services for sexually transmitted infections 
 (STIs), including HIV, Hepatitis B and C, chlamydia, gonorrhea and other 
 conditions.
 
 
 As part of the services, which will be offered in Cincinnati, Cleveland, 
 Columbus (Ohio), Dallas, Denver, Houston, Kansas City, Knoxville, Las 
 Vegas, Louisville, Memphis, Nashville, Orlando, Philadelphia, Phoenix, 
 Tucson, Washington D.C., and Wichita, Healthcare Clinic providers – 
 nurse practitioners and physician assistants - will first conduct a 
 consultation with the patient and, as applicable, conduct the STI 
 testing process. The method of testing varies based on the type of 
 condition being assessed. Healthcare Clinic providers can offer 
 treatment or a referral to a specialist, as needed.
 
 
 In addition to STI testing, Walgreens is also furthering its commitment 
 to supporting communities impacted by HIV through prevention and early 
 detection services. On April 25, providers at Walgreens Healthcare 
 Clinics in the Houston area, can begin prescribing PrEP (Pre-Exposure 
 Prophylaxis), a medication protocol for people who don't have HIV to 
 help proactively protect against HIV infection. When taken daily as 
 directed, PrEP can reduce the risk of HIV infection by more than 90 
 percent when used consistently.
 
 
 Following an initial PrEP consultation with a patient, Healthcare Clinic 
 providers will be able to conduct tests for HIV and other STIs, as 
 needed. Upon review of test results, providers will conduct a follow-up 
 visit and may prescribe PrEP, as necessary.
 
 
 "Offering these new services in our Healthcare Clinics demonstrates our 
 ongoing commitment to improving the comprehensive health and wellbeing 
 of our patients," said Pat Carroll, MD, chief medical officer for 
 Walgreens Healthcare Clinics. "We're proud to introduce the testing 
 services during STD Awareness Month in April, and support the Centers 
 for Disease Control and Prevention (CDC) in raising public awareness 
 about the impact that STDs - the diseases that can develop from STIs – 
 can have on the lives of Americans and the importance of testing and 
 prevention."
 
 
 Glen Pietrandoni, Walgreens senior director, virology disease state, 
 said, "With our long history of working with the HIV/AIDS community, we 
 are as committed as ever to the ongoing, incredible advancement in HIV 
 testing, prevention and treatment that has occurred over the last 
 decade, and to providing greater access to high quality testing and 
 prevention services through the clinics and our pharmacies."
 
 
 Also, as part of this commitment, Walgreens pharmacy staff and store 
 managers chain-wide will be completing HIV Continuing Education (CE) 
 training courses. The curriculum includes a Walgreens-developed HIV 
 stigma course as well as a HIV prevention course developed by Walgreens 
 in collaboration with the National Alliance of HIV Education and 
 Workforce Development (NAHEWD). The educational training also includes 
 tools for improving adherence to PrEP.
 
 
 Pietrandoni said, "With this training, our pharmacy staff will be even 
 more equipped to offer one-on-one medication counseling and other 
 support services that provide our patients living with HIV/AIDS and 
 their families, as well as those at risk for HIV, with compassionate, 
 confidential care."
 
 
 Walgreens also collaborates with health departments and local AIDS 
 service organizations to help provide free HIV testing as part of an 
 ongoing effort to broaden the reach of HIV information and testing in 
 non-traditional settings and to support local organizations' outreach 
 efforts.
 
 
 About Walgreens
 
 
 Walgreens (<a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.walgreens.com&amp;esheet=51541974&amp;newsitemid=20170418005305&amp;lan=en-US&amp;anchor=www.walgreens.com&amp;index=1&amp;md5=73f30892ffa7669621886abee6e16abc" rel="nofollow" rel="nofollow">www.walgreens.com</a>), 
 one of the nation&#39;s largest drugstore chains, is included in the Retail 
 Pharmacy USA Division of Walgreens Boots Alliance, Inc. WBA, 
 the first global pharmacy-led, health and wellbeing enterprise. More 
 than 10 million customers interact with Walgreens each day in 
 communities across America, using the most convenient, multichannel 
 access to consumer goods and services and trusted, cost-effective 
 pharmacy, health and wellness services and advice. Walgreens operates 
 8,175 drugstores with a presence in all 50 states, the District of 
 Columbia, Puerto Rico and the U.S. Virgin Islands, along with its 
 omnichannel business, Walgreens.com. Approximately 400 Walgreens stores 
 offer Healthcare Clinic or other provider retail clinic services.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170418005305r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170418005305/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170418005305/en/</a></body></html>

Press Releases

Walgreens Healthcare Clinics to Offer Testing Services for Sexually Transmitted Infections, Including HIV, Hepatitis and Others - Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance

Walgreens Healthcare Clinics to Offer Testing Services for Sexually Transmitted Infections, Including HIV, Hepatitis and Others

ADTN


ADTRAN Holdings, Inc. (NASDAQ:ADTN, FSE: QH9)), announced today that Company representatives will meet with investors at the Germany Spring Conference 2024 – Equity Forum in Frankfurt Germany May 13-15, 2024.


ADTRAN

ADTRAN Holdings, Inc. to Meet with Investors at the German Spring Conference 2024 – Equity Forum on May 13-15, 2023

INTC

The Law Offices of Frank R. Cruz Announces Investigation of Intel Corporation (INTC) on Behalf of Investors


GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D., to serve as advisors to ReNAgade


Additional investment strengthens ReNAgade&#39;s delivery platform with unique conjugation platform based on novel

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology

SMAL


The Board of Directors of Summit Bancshares, Inc., at a meeting held on April 17, 2024, in recognition of the bank&#39;s 42nd year in business, declared a one-time special cash dividend of $0.42 per share, payable on June

Summit Bancshares, Inc. Announces a Special Dividend


The Board of Directors of Summit Bancshares Inc., at a meeting held on April 17, 2024, declared a quarterly cash dividend of $0.11 per share, payable on June 14, 2024, to holders of record as of the close of business on

Summit Bancshares, Inc. Announces 1st Quarter Cash Dividend

FULT


Fulton doubles regional presence while providing stability to customers


Fulton Financial Corporation (NASDAQ:FULT) (the &#34;Corporation&#34;) today announced that its bank subsidiary, Fulton Bank, N.A. (&#34;Fulton&#34;), has

Fulton Financial Corporation Acquires Substantially All of the Assets and Assumes Substantially All of the Deposits of Republic First Bank From the FDIC